Annual report pursuant to Section 13 and 15(d)

Income Tax - Significant Components of Company's Deferred Tax Assets and Deferred Tax Liabilities (Detail)

v3.19.1
Income Tax - Significant Components of Company's Deferred Tax Assets and Deferred Tax Liabilities (Detail) - USD ($)
$ in Thousands
Dec. 31, 2018
Dec. 31, 2017
Deferred tax assets    
Tax basis in excess of book value of assets $ 886 $ 850
Non-capital loss carryforwards 37,332 33,524
Research and development deductions and credits 5,707 5,506
Stock options 171 51
§59(e) Capitalized R&D expenses 3,334 3,252
Other 170 246
Total deferred tax assets 47,600 43,429
Valuation allowance (47,123) (42,914)
Net deferred assets 477 515
Deferred tax liabilities    
Intangible assets (474) (513)
Other (3) (2)
Total deferred tax liabilities (477) $ (515)
Net deferred tax assets $ 0